Cheryl Xu insider trades
Open-market stock purchases and sales by Cheryl Xu, Director at 60 Degrees Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 31, 2024.
Track record: 0% of 5 scored buys are up 5% or more since purchase, averaging -24%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- SXTP 60 Degrees Pharmaceuticals, Inc: 7 buys, last Jun 3, 2025